Explore groundbreaking research papers, clinical trials, and scientific breakthroughs in hormonal science.
Explore how Proxalutamide (GT0918), a potent androgen receptor pathway inhibitor, is transforming treatment for prostate cancer and COVID-19 through its dual mechanism of action.